Houston, TXNCT07458347Now EnrollingIRB Ready

KRAS-mutant Non-small Cell Lung Cancer (NSCLC) Clinical Trial in Houston, TX

Access cutting-edge kras-mutant non-small cell lung cancer (nsclc) treatment through this clinical trial at a research site in Houston. Study-provided care at no cost to qualified participants.

Sponsored by Kestrel Therapeutics, Inc.

Quick Self-Assessment

See if you qualify for this Houston location

Preparing your pre-screening questions…

Expert Care in Houston

Access kras-mutant non-small cell lung cancer (nsclc) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related kras-mutant non-small cell lung cancer (nsclc) treatment provided free

Apply for This Houston Location

Check if you qualify for this kras-mutant non-small cell lung cancer (nsclc) clinical trial in Houston, TX

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Houston

    Convenient for TX residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Houston site if eligible
  4. 4Begin participation

About This KRAS-mutant Non-small Cell Lung Cancer (NSCLC) Study in Houston

The main purpose of the trial is to assess whether the trial drug, KST-6051, is safe and tolerable when administered orally to adults with advanced or metastatic solid tumors with certain KRAS mutations.

Sponsor: Kestrel Therapeutics, Inc.

Who Can Participate

Inclusion Criteria

Age ≥ 18 years.
Willing and able to give written informed consent.
Histologically documented locally advanced and unresectable or metastatic NSCLC, PDAC, CRC, or other solid tumor.
Documentation of KRAS mutation prior to the first dose of trial drug(s).
Progressed on or intolerant to standard treatment(s).
Eastern Cooperative Oncology Group Performance Status (ECOG PS) of 0 or 1.
Adequate cardiovascular, hematological, liver, and renal function.
Measurable disease at baseline per Response Evaluation Criteria In Solid Tumors version 1.1 (RECIST 1.1).

Exclusion Criteria

Previous or current treatment with RAS or KRAS inhibitors.
Central nervous system (CNS) tumors or metastases.
Inability to swallow oral medications.
Pregnant, breastfeeding, or expecting to conceive or father children within the projected duration of the trial. Other inclusion/exclusion criteria are specified in the protocol.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Houston?

Yes, this clinical trial (NCT07458347) has an active research site in Houston, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

KRAS-mutant Non-small Cell Lung Cancer (NSCLC) Treatment Options in Houston, TX

If you're searching for kras-mutant non-small cell lung cancer (nsclc) treatment options in Houston, TX, this clinical trial (NCT07458347) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Houston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced kras-mutant non-small cell lung cancer (nsclc) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all kras-mutant non-small cell lung cancer (nsclc) clinical trials near you to find additional studies recruiting in your area.

Ready to Join in Houston?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Houston, TX